BBI Detection

BBI Detection is a specialized detection technology business within the broader BBI group, focused on rapid tests and sampling systems for biological threats, explosives, narcotics, and related CBRNe applications. The company appears to operate through both a UK entity, BBI Detection Limited, and a US entity, BBI Detection, LLC, with operations linked to Madison, Wisconsin and the wider BBI network. Its offerings are positioned around assay development, rapid point-of-care style detection, and proprietary sampling tools such as IMASS for field use by military, first responder, and security customers. Unlike a therapeutic biotech company, BBI Detection is primarily a commercial-stage product and technology provider rather than a drug developer. The business is adjacent to healthcare through biological threat detection and diagnostics capabilities, but its core end markets also include defense and security.